Vincristine in Combination Therapy of Cancer: Emerging Trends in Clinics
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vincristine in Combination Therapy of Cancer: Emerging Trends in Clinics
Authors
Keywords
-
Journal
Biology-Basel
Volume 10, Issue 9, Pages 849
Publisher
MDPI AG
Online
2021-08-31
DOI
10.3390/biology10090849
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial
- (2021) James Russell et al. ANNALS OF HEMATOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release
- (2021) Hana Starobova et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Radiotherapy Plus Procarbazine, Lomustine, and Vincristine Versus Radiotherapy Plus Temozolomide for IDH ‐Mutant Anaplastic Astrocytoma: A Retrospective Multicenter Analysis of the French POLA Cohort
- (2021) Vincent Esteyrie et al. ONCOLOGIST
- Chemoreduction with topotecan and vincristine: Quantifying tumor response in bilateral retinoblastoma patients
- (2021) Benjamin A. King et al. PEDIATRIC BLOOD & CANCER
- A novel flavonoid from Fissistigma cupreonitens, 5-hydroxy-7,8-dimethoxyflavanone, competitively inhibited the efflux function of human P-glycoprotein and reversed cancer multi-drug resistance
- (2021) Yu-Ning Teng et al. PHYTOMEDICINE
- Identification of small molecules that mitigate vincristine‐induced neurotoxicity while sensitizing leukemia cells to vincristine
- (2021) Barthelemy Diouf et al. CTS-Clinical and Translational Science
- Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell
- (2021) Ya-Sheng Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation
- (2021) Monika L. Metzger et al. JOURNAL OF CLINICAL ONCOLOGY
- Autophagy Modulators in Cancer Therapy
- (2021) Kamila Buzun et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis
- (2020) Marijke Linschoten et al. Lancet Haematology
- Discovery of Novel Autophagy Inhibitors and Their Sensitization Abilities for Vincristine‐Resistant Esophageal Cancer Cell Line Eca109/VCR
- (2020) Changyu Shan et al. ChemMedChem
- Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma
- (2020) Mark Roschewski et al. JOURNAL OF CLINICAL ONCOLOGY
- Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial
- (2020) Kazuyuki Shimada et al. LANCET ONCOLOGY
- Overcoming vincristine resistance in cancer: Computational design and discovery of piperine‐inspired P‐glycoprotein inhibitors
- (2020) Safiulla Basha Syed et al. Chemical Biology & Drug Design
- Impact of ABVD chemotherapy on ovarian reserve after fertility preservation in reproductive-aged women with Hodgkin lymphoma
- (2020) Catarina Policiano et al. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
- Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma
- (2020) Erica H. Bell et al. JOURNAL OF CLINICAL ONCOLOGY
- A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA
- (2020) Laurie H. Sehn et al. Journal of Hematology & Oncology
- A Metabolomics Approach for Early Prediction of Vincristine-Induced Peripheral Neuropathy
- (2020) Parul Verma et al. Scientific Reports
- Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials
- (2020) Marc P. E. André et al. Cancer Medicine
- Cost-effectiveness of brentuximab vedotin in advanced stage Hodgkin’s lymphoma: a probabilistic analysis
- (2020) A. J. N. Raymakers et al. BMC CANCER
- ABVD and BEACOPP regimens’ effects on fertility in young males with Hodgkin lymphoma
- (2020) M. S. A. Amin et al. Clinical & Translational Oncology
- New Seco-DSP derivatives as potent chemosensitizers
- (2020) Qi Wan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Mitotic Poisons in Research and Medicine
- (2020) Jan Škubník et al. MOLECULES
- Notable response of a young adult with recurrent glioblastoma multiforme to vincristine-irinotecan-temozolomide and bevacizumab
- (2020) Georgios I. Papageorgiou et al. ANTI-CANCER DRUGS
- M‐EA (methotrexate, etoposide, dactinomycin) and EMA‐CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first‐line treatment of high‐risk gestational trophoblastic neoplasia
- (2020) Kam Singh et al. INTERNATIONAL JOURNAL OF CANCER
- Frontline treatment of diffuse large B‐cell lymphoma: Beyond R‐CHOP
- (2019) Patrizia Mondello et al. HEMATOLOGICAL ONCOLOGY
- Autophagy Inhibition in Childhood Nephroblastoma and the Therapeutic Significance
- (2018) Lin-Jie Li et al. CURRENT CANCER DRUG TARGETS
- Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain
- (2018) Katherine Stockstill et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Vincristine, Irinotecan, and Bevacizumab in Relapsed Wilms Tumor With Diffuse Anaplasia
- (2018) Amalia Schiavetti et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study
- (2018) Hagop Kantarjian et al. LANCET ONCOLOGY
- Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma
- (2018) Joseph M. Connors et al. NEW ENGLAND JOURNAL OF MEDICINE
- Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study
- (2018) Loredana Amoroso et al. Cancer Research and Treatment
- Salvage Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini–Hyper-CVD for Patients With Relapsed or Refractory Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia
- (2018) Elias Jabbour et al. JAMA Oncology
- Genomic chaos in peripheral blood lymphocytes of Hodgkin's lymphoma patients one year after ABVD chemotherapy/radiotherapy
- (2018) Sandra Ramos et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- Seco-4-methyl-DCK derivatives as potent chemosensitizers
- (2018) Yalan Guo et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study
- (2018) Tadeusz Robak et al. LANCET ONCOLOGY
- Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study
- (2018) Kieron Dunleavy et al. Lancet Haematology
- A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report
- (2017) Astrid K. Gnekow et al. EUROPEAN JOURNAL OF CANCER
- Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non–Germinal Center B-Cell–Like Diffuse Large B-Cell Lymphoma
- (2017) John P. Leonard et al. JOURNAL OF CLINICAL ONCOLOGY
- Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group
- (2017) Dennis A Eichenauer et al. LANCET ONCOLOGY
- Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas
- (2017) Joseph Roswarski et al. LEUKEMIA & LYMPHOMA
- Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment Improves Survival in Patients with Metastatic and Unresectable Malignant Pheochromocytomas/Paragangliomas
- (2017) Shiko Asai et al. Hormones & Cancer
- Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group
- (2017) Frédéric Peyrade et al. Lancet Haematology
- Recent advances of cocktail chemotherapy by combination drug delivery systems
- (2016) Quanyin Hu et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeting the programmed death-1/programmed death-ligand 1 axis in lymphoma
- (2015) Chan Yoon Cheah et al. CURRENT OPINION IN ONCOLOGY
- Neurotoxic 1-deoxysphingolipids and paclitaxel-induced peripheral neuropathy
- (2015) Rita Kramer et al. FASEB JOURNAL
- A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children's Oncology Group study
- (2015) Murali Chintagumpala et al. NEURO-ONCOLOGY
- Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group
- (2015) Leo Mascarenhas et al. PEDIATRIC BLOOD & CANCER
- Treatment of malignant phaeochromocytoma with a combination of cyclophosphamide, vincristine and dacarbazine: own experience and overview of the contemporary literature
- (2014) Timo Deutschbein et al. CLINICAL ENDOCRINOLOGY
- Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis
- (2014) N.D. Niemeijer et al. CLINICAL ENDOCRINOLOGY
- The Development and Maintenance of Paclitaxel-induced Neuropathic Pain Require Activation of the Sphingosine 1-Phosphate Receptor Subtype 1
- (2014) Kali Janes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation ofIDH
- (2014) J. Gregory Cairncross et al. JOURNAL OF CLINICAL ONCOLOGY
- The Leukemias: A Half-Century of Discovery
- (2014) Emil J. Freireich et al. JOURNAL OF CLINICAL ONCOLOGY
- A previously undescribed tubulin binder
- (2014) J. J. Field et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404)
- (2013) Kristen Ganjoo et al. LEUKEMIA & LYMPHOMA
- Pilot study of vincristine, oral irinotecan, and temozolomide (VOIT regimen) combined with bevacizumab in pediatric patients with recurrent solid tumors or brain tumors
- (2013) Lars Wagner et al. PEDIATRIC BLOOD & CANCER
- Treatment of multiply relapsed wilms tumor with vincristine, irinotecan, temozolomide and bevacizumab
- (2013) Rajkumar Venkatramani et al. PEDIATRIC BLOOD & CANCER
- A Phase I Study of Vincristine, Irinotecan, Temozolomide and Bevacizumab (Vitb) in Pediatric Patients with Relapsed Solid Tumors
- (2013) Rajkumar Venkatramani et al. PLoS One
- Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicity
- (2012) Ibrahim Qaddoumi et al. CANCER
- EMA/CO for High-Risk Gestational Trophoblastic Neoplasia: Good Outcomes With Induction Low-Dose Etoposide-Cisplatin and Genetic Analysis
- (2012) Constantine Alifrangis et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of Advanced Medullary Thyroid Carcinoma with a Combination of Cyclophosphamide, Vincristine, and Dacarbazine: a Single-Center Experience
- (2011) T. Deutschbein et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Doxorubicin: The Good, the Bad and the Ugly Effect
- (2009) Cristina Carvalho et al. CURRENT MEDICINAL CHEMISTRY
- Cyclophosphamide and cancer: golden anniversary
- (2009) Ashkan Emadi et al. Nature Reviews Clinical Oncology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started